Sanofi moves closer to selling controlling stake in $17bn-valued Opella
Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.
Business & Regulation
Valneva hits 2024 sales target but plans lower cash burn in 2025
Trump’s tariffs could strain medicine supply and drive drug costs
Sanofi kicks off share buyback plan with $3bn L’Oréal stake purchase
UK life science startups have trouble “scaling up” says Lord Vallance
MHRA puts technology in the spotlight in 2024/25 business plan
J&J clinches EC approval for first single-pill PAH combo
Epigenetic drugs show 375% increase in Series A venture financing in 2024
